You are here

Article Text

Article menu
Download PDFPDF
Editorial commentary
Is the Pill Questionnaire useless? Your move, MDS Task Force
  1. T van Eimeren
  1. Correspondence to Dr Thilo van Eimeren, Department of Neurology, Schleswig-Holstein University Hospital, Kiel Campus, Arnold-Heller-Str. 3, Kiel D-24105, Germany; tvaneimeren{at}gmail.com

https://doi.org/10.1136/jnnp-2013-307040

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The Pill Questionnaire may severely underestimate impairments in activities of daily living (ADL) in patients with Parkinson's disease (PD).

    Many patients with PD stay cognitively intact, especially if one discounts very mild executive dysfunctions in neuropsychological tests. Notwithstanding the above, it is recognised that increasing disability due to cognitive deficits, that is, dementia, develops in a substantial number of PD patients.1 Affected cognitive domains are variable, often dominated by impairments in executive functions, but may also include impaired visuospatial, constructional attention and memory functions. Point prevalence of dementia associated with PD (PD-D) is roughly 30%, but that number will largely depend on …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles